UA64700C2

Patents

Full documents

Title

Abstract

Claims

All

Any

Exact

Not

Add AND condition

These CPCs and their children

These exact CPCs

Add AND condition

Exact

Exact Batch

Similar

Substructure

Substructure (SMARTS)

Full documents

Claims only

Add AND condition

Application Numbers

Publication Numbers

Either

Add AND condition

Oral pharmaceutical fast-dispersing composition of dopamine agonist and method for treatment of parkinson's disease

Classifications

A61K9/2095

Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

View 3 more classifications

Landscapes

Health & Medical Sciences

Veterinary Medicine

UA64700C2

Ukraine

Download PDF

Find Prior Art

Similar

Other languages: English; Ukrainian

1995

1996

1998

2000

1996-08-16

Application filed

2004-03-15

Publication of UA64700C2

Info: Patent citations (30); Cited by (156); Similar documents; Priority and Related Applications
External links: Espacenet; Global Dossier; Discuss

Patent Citations (30)

Publication number Priority date Publication date Assignee Title

Family To Family Citations

IE45770B1

* 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms

DE3216869A1

* 1982-05-03 1983-11-03 Schering AG, 1000 Berlin und 4709 Bergkamen Synergistische kombination mit zytostatischer wirkung

IT1200609B

* 1985-04-04 1989-01-27 Poli Ind Chimica Spa Composizione farmaceutice per il trattamento delle turbe cerebrovascolari e del cervello anziano

US5288497A

* 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments

US5785989A

1985-05-01 1998-07-28 University Utah Research Foundation Compositions and methods of manufacturing of oral dissolvable medicaments

HU193780B

* 1985-06-21 1987-11-30 Richter Gedeon Vegyeszet Process for producing 2-halogeno-6-methyl-ergol-9-ene derivatives and acid additional salts thereof

JPS63501717A

* 1985-10-29 1988-07-14 ベーカー・カミンス・デルマトロジカルス・インコーポレーテッド抗原誘発性アレルギ−反応を阻止するための方法および組成物

NZ220599A

* 1986-06-16 1990-10-26 Merck & Co Inc Controlled release oral dosage formulation of carbidopa and levodopa

DE3631088A1

* 1986-09-12 1988-06-23 Ferring Arzneimittel Gmbh Verwendung von opiat-antagonisten zur diagnose und therapie von hypothalamischen funktionsstoerungen

US4855326A

* 1987-04-20 1989-08-08 Fuisz Pharmaceutical Ltd. Rapidly dissoluble medicinal dosage unit and method of manufacture

WO1993008699A1

* 1991-11-04 1993-05-13 Fuisz Technologies Ltd. Water-soluble delivery systems for hydrophobic liquids

GB8712073D0

* 1987-05-21 1987-06-24 Smith Kline French Lab Medicament

US5234957A

* 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents

DE3831088A1

* 1988-09-13 1990-03-15 Jochen Gasda Preisauszeichnungseinrichtung und verfahren zum aufbringen von preisauszeichnungen auf einen preisauszeichnungstraeger

US5073374A

* 1988-11-30 1991-12-17 Schering Corporation Fast dissolving buccal tablet

US5079018A

1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs

DK0494972T3

1989-10-02 1997-05-12 Cima Labs Inc Brusedosisform samt fremgangsmåde til administration heraf

GB9015095D0

* 1990-07-09 1990-08-29 Smith Kline French Lab Therapeutic method

GB9216297D0

* 1991-08-15 1992-09-16 Ici Plc Therapeutic agents

FI943042A7

* 1991-12-24 1994-06-23 Yamanouchi Pharmaceutical Co Ltd Suuontelossa hajoava valmiste ja sen valmistus

EP0553777B1

* 1992-01-29 2002-04-24 Takeda Chemical Industries, Ltd. Fast dissolving tablet and its production

HUT75616A

* 1992-03-17 1997-05-28 Pfizer Method for prooucing porous delivery devices

US5298261A

1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet

IL105553A

* 1992-05-06 1998-01-04 Janssen Pharmaceutica Inc Solid dosage form comprising a porous network of matrix forming material which disperses rapidly in water

CA2095776C

* 1992-05-12 2007-07-10 Richard C. Fuisz Rapidly dispersable compositions containing polydextrose

IL108366A

* 1993-03-11 1999-11-30 Taro Vit Ind Ltd Semi-solid pharmaceutical compounds and a device for their use

ES2194867T3

* 1993-03-26 2003-12-01 Franciscus Wilhelmus He Merkus Composiciones farmaceuticas para la administracion intranasal de apomorfina.

DE4320678C2

1993-06-22 1996-04-11 Branko Dipl Ing Klasnic Vorrichtung zum Entfernen von Rechengut aus einer mit einer verunreinigten Flüssigkeit durchströmten Zulaufrinne, insbesondere von Kläranlagen

GB9421836D0

* 1994-10-28 1994-12-14 Scherer Corp R P Process for preparing solid pharmaceutical dosage forms of hydrophobic substances

GB9517062D0

1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions

* Cited by examiner, † Cited by third party

Cited By (156)

Publication number Priority date Publication date Assignee Title

Family To Family Citations

US6121276A

* 1994-04-22 2000-09-19 Pentech Pharmaceuticals, Inc. Apomorphine-containing dosage forms for ameliorating male erectile dysfunction

US5888534A

* 1995-06-13 1999-03-30 Pentech Pharmaceuticals, Inc. Controlled release of drugs delivered by sublingual or buccal administration

GB9517062D0

1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions

GB9700878D0

* 1997-01-17 1997-03-05 Scherer Ltd R P Dosage forms and method for ameliorating male erectile dysfunction

US20040023948A1

* 1997-03-24 2004-02-05 Green Richard David Fast-dispersing dosage form containing 5-HT1 agonists

CA2291160C

* 1997-05-19 2008-10-28 Zonagen, Inc. Combination therapy for modulating the human sexual response

CH694573A5

1997-07-01 2005-04-15 Technology Finance Corp Zusammensetzungen mit rascher Freigabe.

US20030118645A1

* 1998-04-29 2003-06-26 Pather S. Indiran Pharmaceutical compositions for rectal and vaginal administration

US6974590B2

1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent

US20030091629A1

1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent

GB9904911D0

* 1999-03-03 1999-04-28 Scherer Ltd R P Pharmaceutical compositions

GB9908014D0

* 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions

CZ20022245A3

* 1999-12-30 2002-10-16 Tap Holdings, Inc. Orální mukózní dávkovací formy apomorfinu

AU2001286418A1

* 2000-08-08 2002-02-18 Teva Pharmaceutical Industries Ltd. Stable pergolide mesylate and process for making same

NZ524741A

* 2000-08-16 2005-01-28 Upjohn Co Heterocyclic amines, phenylazacycloalkanes, cabergoline and aromatic bicyclic amines for the treatment of alcohol, nicotine and drug addiction

SE0002934D0

2000-08-17 2000-08-17 Axon Biochemicals Bv New aporphine esters and in their use in therapy

SE0102036D0

* 2001-06-08 2001-06-08 Axon Biochemicals Bv Pharmaceutical formulation for the efficient administration of apomorphine, 6aR- (-) -N- Propyl- norapomorphine and their derivatives and pro-drugs thereof

WO2002032403A1

* 2000-10-16 2002-04-25 Daiichi Pharmaceutical Co., Ltd. Medicinal compositions quickly disintegrating in the oral cavity and process for producing the same

DE10107659B4

* 2001-02-19 2008-03-13 Lts Lohmann Therapie-Systeme Ag Mucoadhäsive zerfallsfähige Arzneizubereitung zur Wirkstoffverabreichung in der Veterinär- und Humanmedizin

US20030068356A1

* 2001-07-10 2003-04-10 Pather S. Indiran Sequential drug delivery systems

FR2834894B1

* 2002-01-21 2004-02-27 Servier Lab Composition pharmaceutique orodispersible de piribedil

CA2478093A1

2002-02-28 2003-09-12 A & D Bioscience, Inc. Glycuronamides, glycosides and orthoester glycosides of fluoxetine, analogs and uses thereof

US20050107310A1

* 2002-03-19 2005-05-19 Holick Michael F. Carboxylic acid glycuronides, glycosamides and glycosides of quinolones, penicillins, analogs, and uses thereof

WO2003080074A1

* 2002-03-19 2003-10-02 Michael Holick Glycoside and orthoester glycoside derivatives of apomorphine, analogs, and uses thereof

WO2003084504A2

* 2002-04-05 2003-10-16 Euro-Celtique S.A. Matrix for sustained, invariant and independent release of active compounds

US20050255038A1

* 2002-04-12 2005-11-17 A And D Bioscience, Inc. Conjugates comprising cancer cell specific ligands, a sugar and diagnostic agents and uses thereof

WO2003092591A2

* 2002-04-30 2003-11-13 Npd Llc Multi-phasic delivery via transmucosal absorption of antiemetic medicaments

CA2484891A1

* 2002-05-07 2003-11-20 A & D Bioscience, Inc. Conjugates comprising central nervous system active drug

WO2004000223A2

* 2002-06-20 2003-12-31 Orapharma, Inc. Rapidly disintegrating formulations for treating or preventing mucositis

US20050215487A1

* 2002-06-27 2005-09-29 Holick Michael F Conjugates comprising an nsaid and a sugar and uses thereof

GB0217056D0

* 2002-07-23 2002-08-28 Ass Octel Use

US8821915B2

2002-08-09 2014-09-02 Veroscience, Llc Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders

GB0226076D0

* 2002-11-08 2002-12-18 Rp Scherer Technologies Inc Improved formulations containing substituted imidazole derivatives

US20040156894A1

* 2003-02-07 2004-08-12 Grother Leon Paul Use of edible acids in fast-dispersing pharmaceutical solid dosage forms

RU2224518C1

* 2003-02-10 2004-02-27 Дулькис Мария Дмитриевна Жидкая лекарственная форма налтрексона

DE602004012403T2

2003-04-29 2009-03-19 Orexigen Therapeutics, Inc., La Jolla Zusammensetzungen zur beeinflussung des gewichtsverlusts

MXPA06007453A

* 2003-12-31 2007-01-31 Cima Labs Inc Forma de dosificacion de opiaceo oral efervescente.

WO2005065317A2

2003-12-31 2005-07-21 Cima Labs Inc. Effervescent oral fentanyl dosage form

PT1708686E

* 2003-12-31 2011-04-20 Cima Labs Inc Forma de dosagem de fentanil oral efervescente geralmente linear e métodos de administração

US7576073B2

2004-05-28 2009-08-18 UNIVERSITé LAVAL Combined therapy for the treatment of parkinson's disease

US7972621B2

* 2004-06-03 2011-07-05 R.P. Scherer Technologies, Llc Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight

CA2568445C

* 2004-06-17 2011-05-24 Merz Pharma Gmbh & Co. Kgaa Immediate release formulations of memantine oral dosage forms

WO2006047861A1

* 2004-11-03 2006-05-11 Clera Inc. Method to detect dopamine receptors in the functional d2high state

US20080193526A1

* 2005-03-28 2008-08-14 Anders Pettersson Pharmaceutical Compositions Useful in the Treatment of Pain

GB0509317D0

* 2005-05-06 2005-06-15 Clarke Anthony Pharmaceutical formulation of apomorphine

US20070128285A1

* 2005-07-12 2007-06-07 Chikara Jin Pharmaceutical composition for oral administration

US20070020186A1

2005-07-22 2007-01-25 Alpex Pharma S.A. Solid dosage formulations of narcotic drugs having improved buccal adsorption

US20070105867A1

* 2005-09-21 2007-05-10 Bristol-Myers Squibb Company Oral administration of N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-1,3-thiazole-5-carboxamide and salts thereof

EP2292220A3

2005-11-22 2012-01-04 Orexigen Therapeutics, Inc. Composition and methods for increasing insulin sensitivity

US8916195B2

2006-06-05 2014-12-23 Orexigen Therapeutics, Inc. Sustained release formulation of naltrexone

WO2007147133A1

* 2006-06-15 2007-12-21 Serenex, Inc. Stabilized tetracycline compositions

DE102006027793A1

* 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Opioid-Kombinations-Wafer

US20080014228A1

* 2006-07-14 2008-01-17 Olivia Darmuzey Solid form

EP1897543A1

2006-08-30 2008-03-12 Euro-Celtique S.A. Buprenorphine- wafer for drug substitution therapy

KR20180066272A

2006-11-09 2018-06-18 오렉시젠 세러퓨틱스 인크. 단위 용량 팩키지

US20080311162A1

* 2007-05-16 2008-12-18 Olivia Darmuzey Solid form

US20100035886A1

2007-06-21 2010-02-11 Veroscience, Llc Parenteral formulations of dopamine agonists

US8741918B2

2007-06-21 2014-06-03 Veroscience Llc Parenteral formulations of dopamine agonists

GB2463833B

* 2007-06-26 2012-02-08 Parkinson S Inst Compositions that prevent or reverse alpha-synuclein fibrillation for use in the treatment of neurological disorders

US20090004248A1

* 2007-06-29 2009-01-01 Frank Bunick Dual portion dosage lozenge form

US20090004231A1

2007-06-30 2009-01-01 Popp Shane M Pharmaceutical dosage forms fabricated with nanomaterials for quality monitoring

EP2303025A4

2008-05-30 2012-07-04 Orexigen Therapeutics Inc METHOD FOR TREATING DIGITAL FAT SWITCHES

WO2010019856A1

* 2008-08-15 2010-02-18 The Mclean Hospital Corporation Methods and kits for treatings stroke and other neurological conditions

DE102009036285A1

* 2008-10-13 2010-04-15 Illinois Tool Works Inc., Glenview Verfahren zur Herstellung eines Bohrers, insbesondere eines Gesteinsbohrers

US20100116281A1

2008-11-07 2010-05-13 Jerry Wayne Marshall Tobacco products and processes

US9352025B2

2009-06-05 2016-05-31 Veroscience Llc Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders

CN102480958B

2009-06-12 2015-08-19 Cynapsus疗法有限公司舌下阿扑吗啡

WO2011026080A1

2009-08-31 2011-03-03 Wilmington Pharmaceuticals, Llc Fast disintegrating compositions of meloxicam, processes for preparation, and use to treat arthritis and/or pain

UA108360C2

2009-10-01 2015-04-27 Тверда фармацевтична композиція кортикостероїду, що розпадається у ротовій порожнині

US12186426B2

2009-10-30 2025-01-07 Ix Biopharma Ltd. Solid dosage form

PL3254676T3

2009-10-30 2019-06-28 Ix Biopharma Ltd Szybko rozpuszczająca się stała postać dawkowana

MX344303B

2010-01-11 2016-12-13 Orexigen Therapeutics Inc Metodos para proveer terapia de perdida de peso en pacientes con depresion mayor.

US9675102B2

2010-09-07 2017-06-13 R. J. Reynolds Tobacco Company Smokeless tobacco product comprising effervescent composition

HUE052853T2

* 2010-10-08 2021-05-28 Scherer Technologies Llc R P Orális vakcina gyorsan oldódó dózisforma, keményítõ alkalmazásával

CA3115378A1

2010-12-16 2012-06-21 Sunovion Pharmaceuticals Inc. Sublingual films comprising apomorphine and an organic base

US10881132B2

2011-12-14 2021-01-05 R.J. Reynolds Tobacco Company Smokeless tobacco product comprising effervescent composition

CA2875056C

2012-06-06 2024-03-26 Orexigen Therapeutics, Inc. Methods of treating overweight and obesity

KR102305865B1

2013-03-15 2021-09-27 레이 스트라티직 홀딩스, 인크. 재료 시트로 형성된 가열 요소, 애토마이저의 제조를 위한 인풋 및 방법, 에어로졸 송달 장치용 카트리지 및 흡연 물품용 카트리지를 조립하는 방법

WO2015034678A2

2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis

JP2016535794A

* 2013-11-11 2016-11-17 インパックスラボラトリーズ，インコーポレーテッド急速崩壊性製剤及びその使用法

US8969371B1

2013-12-06 2015-03-03 Orexigen Therapeutics, Inc. Compositions and methods for weight loss in at risk patient populations

CA3019769C

2015-04-21 2021-10-12 Sunovion Pharmaceuticals Inc. Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa

US10611505B2

2015-05-04 2020-04-07 Rai Strategic Holdings, Inc. Dispensing machine for aerosol precursor

US10238145B2

2015-05-19 2019-03-26 Rai Strategic Holdings, Inc. Assembly substation for assembling a cartridge for a smoking article

US20170112194A1

2015-10-21 2017-04-27 Rai Strategic Holdings, Inc. Rechargeable lithium-ion capacitor for an aerosol delivery device

US10820630B2

2015-11-06 2020-11-03 Rai Strategic Holdings, Inc. Aerosol delivery device including a wirelessly-heated atomizer and related method

US10104912B2

2016-01-20 2018-10-23 Rai Strategic Holdings, Inc. Control for an induction-based aerosol delivery device

US10334880B2

2016-03-25 2019-07-02 Rai Strategic Holdings, Inc. Aerosol delivery device including connector comprising extension and receptacle

US11207478B2

2016-03-25 2021-12-28 Rai Strategic Holdings, Inc. Aerosol production assembly including surface with micro-pattern

US10405579B2

2016-04-29 2019-09-10 Rai Strategic Holdings, Inc. Methods for assembling a cartridge for an aerosol delivery device, and associated systems and apparatuses

US11019847B2

2016-07-28 2021-06-01 Rai Strategic Holdings, Inc. Aerosol delivery devices including a selector and related methods

TWI777515B

2016-08-18 2022-09-11 美商愛戴爾製藥股份有限公司治療嗜伊紅性食道炎之方法

US10477896B2

2016-10-12 2019-11-19 Rai Strategic Holdings, Inc. Photodetector for measuring aerosol precursor composition in an aerosol delivery device

US20180132529A1

2016-11-14 2018-05-17 Rai Strategic Holdings, Inc. Aerosol delivery device with integrated wireless connectivity for temperature monitoring

US20180132528A1

2016-11-14 2018-05-17 Rai Strategic Holdings, Inc. Photoelectric proximity sensor for gesture-based control of an aerosol delivery device

US10524508B2

2016-11-15 2020-01-07 Rai Strategic Holdings, Inc. Induction-based aerosol delivery device

US10537137B2

2016-11-22 2020-01-21 Rai Strategic Holdings, Inc. Rechargeable lithium-ion battery for an aerosol delivery device

KR102778916B1

2016-12-01 2025-03-07 레이 스트라티직 홀딩스, 인크. 에어로졸 전달 장치 및 제어 바디

CN119924598A

2016-12-02 2025-05-06 莱战略控股公司用于气溶胶递送设备的感应充电

US11013266B2

2016-12-09 2021-05-25 Rai Strategic Holdings, Inc. Aerosol delivery device sensory system including an infrared sensor and related method

US10517326B2

2017-01-27 2019-12-31 Rai Strategic Holdings, Inc. Secondary battery for an aerosol delivery device

US10759554B2

2017-02-02 2020-09-01 Rai Strategic Holdings, Inc. Dispenser unit for aerosol precursor

US10827783B2

2017-02-27 2020-11-10 Rai Strategic Holdings, Inc. Digital compass for an aerosol delivery device

US10314340B2

2017-04-21 2019-06-11 Rai Strategic Holdings, Inc. Refillable aerosol delivery device and related method

US11297876B2

2017-05-17 2022-04-12 Rai Strategic Holdings, Inc. Aerosol delivery device

US10517330B2

2017-05-23 2019-12-31 RAI Stategic Holdings, Inc. Heart rate monitor for an aerosol delivery device

US11337456B2

2017-07-17 2022-05-24 Rai Strategic Holdings, Inc. Video analytics camera system for an aerosol delivery device

US10349674B2

2017-07-17 2019-07-16 Rai Strategic Holdings, Inc. No-heat, no-burn smoking article

US10791761B2

2017-08-17 2020-10-06 Rai Strategic Holdings, Inc. Microtextured liquid transport element for aerosol delivery device

US11039645B2

2017-09-19 2021-06-22 Rai Strategic Holdings, Inc. Differential pressure sensor for an aerosol delivery device

US10505383B2

2017-09-19 2019-12-10 Rai Strategic Holdings, Inc. Intelligent charger for an aerosol delivery device

US10660370B2

2017-10-12 2020-05-26 Rai Strategic Holdings, Inc. Aerosol delivery device including a control body, an atomizer body, and a cartridge and related methods

US12114688B2

2017-10-24 2024-10-15 Rai Strategic Holdings, Inc. Method for formulating aerosol precursor for aerosol delivery device

US10806181B2

2017-12-08 2020-10-20 Rai Strategic Holdings, Inc. Quasi-resonant flyback converter for an induction-based aerosol delivery device

US10555558B2

2017-12-29 2020-02-11 Rai Strategic Holdings, Inc. Aerosol delivery device providing flavor control

US10813385B2

2018-03-09 2020-10-27 Rai Strategic Holdings, Inc. Buck regulator with operational amplifier feedback for an aerosol delivery device

US11206864B2

2018-03-26 2021-12-28 Rai Strategic Holdings, Inc. Aerosol delivery device providing flavor control

US10959459B2

2018-05-16 2021-03-30 Rai Strategic Holdings, Inc. Voltage regulator for an aerosol delivery device

US11094993B2

2018-08-10 2021-08-17 Rai Strategic Holdings, Inc. Charge circuitry for an aerosol delivery device

US10939707B2

2018-08-23 2021-03-09 Rai Strategic Holdings, Inc. Aerosol delivery device with segmented electrical heater

US11592793B2

2018-11-19 2023-02-28 Rai Strategic Holdings, Inc. Power control for an aerosol delivery device

US11614720B2

2018-11-19 2023-03-28 Rai Strategic Holdings, Inc. Temperature control in an aerosol delivery device

US11753750B2

2018-11-20 2023-09-12 R.J. Reynolds Tobacco Company Conductive aerosol generating composite substrate for aerosol source member

US11547816B2

2018-11-28 2023-01-10 Rai Strategic Holdings, Inc. Micropump for an aerosol delivery device

US11096419B2

2019-01-29 2021-08-24 Rai Strategic Holdings, Inc. Air pressure sensor for an aerosol delivery device

US20200245696A1

2019-02-06 2020-08-06 Rai Strategic Holdings, Inc. Buck-boost regulator circuit for an aerosol delivery device

US11456480B2

2019-02-07 2022-09-27 Rai Strategic Holdings, Inc. Non-inverting amplifier circuit for an aerosol delivery device

US12140978B2

2019-03-01 2024-11-12 Rai Strategic Holdings, Inc. Temperature control circuitry for an aerosol delivery device

US11324249B2

2019-03-06 2022-05-10 R.J. Reynolds Tobacco Company Aerosol delivery device with nanocellulose substrate

UA128433C2

2019-03-08 2024-07-10 Раі Стретеджік Холдінгс, Інк. Спосіб одержання попередника аерозолю

US11935350B2

2019-04-02 2024-03-19 Rai Strategic Holdings, Inc. Functional control and age verification of electronic devices through speaker communication

US11676438B2

2019-04-02 2023-06-13 Rai Strategic Holdings, Inc. Authentication and age verification for an aerosol delivery device

US11200770B2

2019-04-02 2021-12-14 Rai Strategic Holdings, Inc. Functional control and age verification of electronic devices through visual communication

US11783395B2

2019-04-24 2023-10-10 Rai Strategic Holdings, Inc. Decentralized identity storage for tobacco products

US11690405B2

2019-04-25 2023-07-04 Rai Strategic Holdings, Inc. Artificial intelligence in an aerosol delivery device

US12232543B2

2019-05-17 2025-02-25 Rai Strategic Holdings, Inc. Age verification with registered cartridges for an aerosol delivery device

US12022859B2

2019-07-18 2024-07-02 R.J. Reynolds Tobacco Company Thermal energy absorbers for tobacco heating products

US20210059301A1

2019-08-29 2021-03-04 Rai Strategic Holdings, Inc. Dual-chamber aerosol dispenser

GB201912686D0

2019-09-04 2019-10-16 Reown Pharma Inc Pharmaceutical composition

US11785991B2

2019-10-04 2023-10-17 Rai Strategic Holdings, Inc. Use of infrared temperature detection in an aerosol delivery device

US11470689B2

2019-10-25 2022-10-11 Rai Strategic Holdings, Inc. Soft switching in an aerosol delivery device

JP7585322B2

2019-11-18 2024-11-18 アール・エイ・アイ・ストラテジック・ホールディングス・インコーポレイテッドセキュリティタグ

JP7702408B2

2019-12-30 2025-07-03 アール・エイ・アイ・ストラテジック・ホールディングス・インコーポレイテッドエアロゾル送達デバイス用の心拍数モニタ

US12178258B2

2020-03-26 2024-12-31 Rai Strategic Holdings, Inc. Methods, apparatuses and systems for waking a device prior to device activation

US20210321655A1

2020-04-16 2021-10-21 R.J. Reynolds Tobacco Company Aerosol delivery device including a segregated substrate

US20210321674A1

2020-04-21 2021-10-21 Rai Strategic Holdings, Inc. Pressure-sensing user interface for an aerosol delivery device

US11839240B2

2020-04-29 2023-12-12 Rai Strategic Holdings, Inc. Piezo sensor for a power source

WO2021250516A1

2020-06-08 2021-12-16 Nicoventures Trading Limited Effervescent oral composition comprising an active ingredient

US11771132B2

2020-08-27 2023-10-03 Rai Strategic Holdings, Inc. Atomization nozzle for aerosol delivery device

US11771136B2

2020-09-28 2023-10-03 Rai Strategic Holdings, Inc. Aerosol delivery device

US11672761B2

2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans

US20220183389A1

2020-12-11 2022-06-16 Rai Strategic Holdings, Inc. Sleeve for smoking article

EP4326098A1

2021-04-22 2024-02-28 Nicoventures Trading Limited Effervescent oral composition

WO2024231554A1

2023-05-11 2024-11-14 Catalent U.K. Swindon Zydis Limited Increasing permeation for pre-gastric absorption of active pharmaceutical ingredients

WO2025064381A1

* 2023-09-18 2025-03-27 Phathom Pharmaceuticals Inc. Method for preparing vonoprazan with reduced nitrosamine

EP4585059A1

2024-01-12 2025-07-16 Nicoventures Trading Limited Effervescent pouched product

* Cited by examiner, † Cited by third party, ‡ Family to family citation

Priority And Related Applications

Applications Claiming Priority (2)

Application Filing date Title

GBGB9517062.7A

1995-08-18 Pharmaceutical compositions

PCT/GB1996/002020

1996-08-16 Oral fast-dissolving compositions for dopamine agonists

Concepts

Download

Name Image Sections Count Query match

mixture

title,claims,abstract,description 86 0.000

dopamine receptor stimulating agent

title,claims,abstract,description 55 0.000

Parkinson disease

title,claims,abstract,description 21 0.000

method

title,claims,description 27 0.000

dosage form

claims,abstract,description 42 0.000

antiemetic agent

claims,abstract,description 33 0.000

anti-emetic effect

claims,abstract,description 25 0.000

mouth

claims,abstract,description 17 0.000

pharmaceutical composition

claims,abstract,description 7 0.000

active ingredient

claims,abstract,description 6 0.000

apomorphine

claims,description 76 0.000

apomorphine

claims,description 61 0.000

citric acid

claims,description 39 0.000

water

claims,description 24 0.000

Gelatin

claims,description 18 0.000

gelatin

claims,description 18 0.000

gelatine

claims,description 18 0.000

gelatine desserts

claims,description 18 0.000

D-Mannitol

claims,description 17 0.000

Mannitol

claims,description 17 0.000

gelatin

claims,description 17 0.000

mannitol

claims,description 17 0.000

mannitol

claims,description 17 0.000

chemical substances by application

claims,description 15 0.000

freeze drying

claims,description 15 0.000

Glycine

claims,description 14 0.000

antiemetic agent

claims,description 13 0.000

salts

claims,description 12 0.000

dispersion

claims,description 11 0.000

food flavoring agent

claims,description 11 0.000

(6ar)-6-methyl-5,6,6a,7-tetrahydro-4h-dibenzo[de,g]quinoline-10,11-diol;hydrochloride

claims,description 8 0.000

apomorphine hydrochloride

claims,description 8 0.000

solid dosage form

claims,description 8 0.000

Glycine

claims,description 7 0.000

flavoring agent

claims,description 7 0.000

solvent

claims,description 7 0.000

narcotic antagonist

claims,description 6 0.000

pharmaceutical excipient

claims,description 6 0.000

food sweetener

claims,description 5 0.000

sweetening agent

claims,description 5 0.000

bromocriptine

claims,description 4 0.000

bromocriptine

claims,description 4 0.000

colorant

claims,description 4 0.000

pH adjusting agent

claims,description 4 0.000

surface-active agent

claims,description 4 0.000

(3r,4ar,10as)-3-(diethylsulfamoylamino)-6-hydroxy-1-propyl-3,4,4a,5,10,10a-hexahydro-2h-benzo[g]quinoline

claims,description 3 0.000

Cabaser

claims,description 3 0.000

Revanil

claims,description 3 0.000

Terguride

claims,description 3 0.000

agonist

claims,description 3 0.000

antioxidant agent

claims,description 3 0.000

cabergoline

claims,description 3 0.000

flavors

claims,description 3 0.000

lisuride

claims,description 3 0.000

metergoline

claims,description 3 0.000

metergoline

claims,description 3 0.000

naxagolide

claims,description 3 0.000

naxagolide

claims,description 3 0.000

pergolide

claims,description 3 0.000

pergolide

claims,description 3 0.000

preservative agent

claims,description 3 0.000

quinagolide

claims,description 3 0.000

solid

claims,description 3 0.000

terguride

claims,description 3 0.000

freezing

claims,description 2 0.000

freezing

claims,description 2 0.000

solid unit dosage form

claims 4 0.000

sublimation

claims 2 0.000

sublimation

claims 2 0.000

thickening agent

claims 2 0.000

opiate agonist

claims 1 0.000

opiate antagonist

abstract,description 25 0.000

co-administration

abstract,description 4 0.000

evaluation

abstract,description 2 0.000

manufacturing process

abstract,description 2 0.000

Show all concepts from the description section

Data provided by IFI CLAIMS Patent Services